Haemonetics
HAE
HAE
269 hedge funds and large institutions have $5.05B invested in Haemonetics in 2020 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 84 increasing their positions, 104 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
12% less capital invested
Capital invested by funds: $5.74B → $5.05B (-$693M)
19% less repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 104
38% less first-time investments, than exits
New positions opened: 43 | Existing positions closed: 69
Holders
269
Holding in Top 10
5
Calls
$12.1M
Puts
$13.7M
Top Buyers
| 1 | +$89.6M | |
| 2 | +$55.5M | |
| 3 | +$51.7M | |
| 4 |
AAMU
AEGON Asset Management (UK)
Edinburgh,
United Kingdom
|
+$49.8M |
| 5 |
Goldman Sachs
New York
|
+$46.7M |
Top Sellers
| 1 | -$287M | |
| 2 | -$39.8M | |
| 3 | -$35.1M | |
| 4 |
Renaissance Technologies
New York
|
-$25.5M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$20.1M |